149 related articles for article (PubMed ID: 27375122)
1. Hematopoietic Cell Transplantation for Richter Syndrome.
El-Asmar J; Kharfan-Dabaja MA
Biol Blood Marrow Transplant; 2016 Nov; 22(11):1938-1944. PubMed ID: 27375122
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center Experience.
Kharfan-Dabaja MA; Kumar A; Stingo FE; Khimani F; Hussaini M; Ayala E; Nishihori T; Shah B; Locke FL; Pinilla-Ibarz J; Chavez JC
Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e35-e39. PubMed ID: 29126867
[TBL] [Abstract][Full Text] [Related]
3. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
[TBL] [Abstract][Full Text] [Related]
4. Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
Herrera AF; Ahn KW; Litovich C; Chen Y; Assal A; Bashir Q; Bayer RL; Coleman M; DeFilipp Z; Farhadfar N; Greenwood M; Hahn T; Horwitz M; Jacobson C; Jaglowski S; Lachance S; Langston A; Mattar B; Maziarz RT; McGuirk J; Mian MAH; Nathan S; Phillips A; Rakszawski K; Sengeloev H; Shenoy S; Stuart R; Sauter CS; Kharfan-Dabaja MA; Hamadani M
Blood Adv; 2021 Sep; 5(18):3528-3539. PubMed ID: 34496026
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis.
Aulakh S; Reljic T; Yassine F; Ayala E; Chavez JC; Chanan-Khan A; Pinilla-Ibarz J; Kumar A; Kharfan-Dabaja MA
Hematol Oncol Stem Cell Ther; 2021 Mar; 14(1):33-40. PubMed ID: 32473105
[TBL] [Abstract][Full Text] [Related]
6. [Richter Syndrome: Diagnostic and Therapeutic Management].
Croizier C; Guièze R
Bull Cancer; 2021 May; 108(5):521-527. PubMed ID: 33896586
[TBL] [Abstract][Full Text] [Related]
7. Successful allogeneic hematopoietic stem cell transplantation in a young patient with Richter syndrome presenting with chronic lymphocytic leukemia and diffuse large B-cell lymphoma with different cell origins.
Rai S; Matsuda M; Yamairi N; Eguchi G; Iwanaga T; Morita Y; Tanaka H; Tatsumi Y; Ashida T; Matsumura I
Intern Med; 2013; 52(2):273-6. PubMed ID: 23318862
[TBL] [Abstract][Full Text] [Related]
8. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
Jamroziak K; Tadmor T; Robak T; Polliack A
Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
[TBL] [Abstract][Full Text] [Related]
9. Richter transformation of CLL.
Jain N; Keating MJ
Expert Rev Hematol; 2016 Aug; 9(8):793-801. PubMed ID: 27351634
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell allografting for chronic lymphocytic leukemia: a focus on reduced-intensity conditioning regimens.
Kharfan-Dabaja MA; Bazarbachi A
Cancer Control; 2012 Jan; 19(1):68-75. PubMed ID: 22143063
[TBL] [Abstract][Full Text] [Related]
11. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.
Salihoglu A; Ozbalak M; Keskin D; Tecimer T; Soysal T; Ferhanoglu B
Transplant Proc; 2013 Sep; 45(7):2845-8. PubMed ID: 23747187
[TBL] [Abstract][Full Text] [Related]
12. [Richter syndrome: clinical characteristics and treatment experiences].
Li ZJ; Xu Y; Zhang PH; Liu W; Yi SH; Zou DH; Qi JY; Zhao YZ; Qiu LG
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3254-6. PubMed ID: 23328508
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Sorror ML; Maris MB; Sandmaier BM; Storer BE; Stuart MJ; Hegenbart U; Agura E; Chauncey TR; Leis J; Pulsipher M; McSweeney P; Radich JP; Bredeson C; Bruno B; Langston A; Loken MR; Al-Ali H; Blume KG; Storb R; Maloney DG
J Clin Oncol; 2005 Jun; 23(16):3819-29. PubMed ID: 15809448
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials.
Sousa-Pimenta M; Martins Â; Mariz JM; Berraondo P
Front Immunol; 2023; 14():1295293. PubMed ID: 38077330
[TBL] [Abstract][Full Text] [Related]
17. Rapid complete response to blinatumomab as a successful bridge to allogeneic stem cell transplantation in a case of refractory Richter syndrome.
Alderuccio JP; Mackrides N; Chapman JR; Vega F; Lossos IS
Leuk Lymphoma; 2019 Jan; 60(1):230-233. PubMed ID: 29745744
[No Abstract] [Full Text] [Related]
18. [Clonality analysis and mutational status of IgVH gene in Hodgkin variant of Richter syndrome].
Mao ZR; Rosenwald A; Zhang SJ; Zhou R; Mueller-Hermelink HK
Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):523-8. PubMed ID: 19094463
[TBL] [Abstract][Full Text] [Related]
19. Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
Khan M; Siddiqi R; Thompson PA
Ann Hematol; 2018 Jan; 97(1):1-15. PubMed ID: 29063177
[TBL] [Abstract][Full Text] [Related]
20. Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
Tadmor T; Shvidel L; Bairey O; Goldschmidt N; Ruchlemer R; Fineman R; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A;
Am J Hematol; 2014 Nov; 89(11):E218-22. PubMed ID: 25110869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
